ITH Pharma ApS

CVR 44743167 · Private limited company (ApS) · Active · Medium risk

ITH Pharma ApS is a Private limited company (ApS), founded on , based in Dianalund. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 655k and a net result of DKK 575k. CEO: Ivan Knud Holmelund Thage.

Bankruptcy risk for ITH Pharma ApS

1.4%
probability of bankruptcy within 12 months
Medium risk

1.0 × the average (1.41%) · higher risk than 75% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)2 yrs · bankruptcy rate 18.9%2.1×
Published annual reports2 · bankruptcy rate 16.7%1.9×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Return on assets15%+ · bankruptcy rate 5.1%0.58×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44743167
Status
Active
Company type
Private limited company (ApS)
Founded
(2 years)
Address
Øllemosen 7
4293 Dianalund
Municipality
Sorø
Industry
Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Speditører
Share capital
DKK 40k
Auditor
Beierholm
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 2
Missing annual reportNo
Negative equityNo
Equity ratio62.3%
Current ratio266%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address2
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 1.9mDKK 285k
Net profitDKK 575kDKK 175k
EquityDKK 655kDKK 215k
Total assetsDKK 1.1mDKK 361k
CashDKK 719kDKK 246k
Short-term debtDKK 395kDKK 94k
Tax owedDKK 168k–
Avg. employees2–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Beierholm.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025181
2 Apr 2024 – 31 Dec 202449

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOIvan Knud Holmelund ThageCurrent
Owner (100%)ITH Holding ApSCurrent
Owner (100%)Ivan Knud Holmelund Thage
FounderIvan Knud Holmelund ThageCurrent

The CEOs' other companies

Ivan Knud Holmelund Thage – 1 other companies

Address history (0 moves)

Øllemosen 7, 4293 Dianalund

Former names

ITH Pharma ApS – now
ITH Pharma Logistics ApS –

Other companies at the same address

Similar companies in Sorø

Questions and answers about ITH Pharma ApS

Has ITH Pharma ApS gone bankrupt?

No, ITH Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of ITH Pharma ApS?

Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.

Who is the CEO of ITH Pharma ApS?

Ivan Knud Holmelund Thage is the CEO of ITH Pharma ApS.

Who is the auditor of ITH Pharma ApS?

ITH Pharma ApS most recently used Beierholm.

When was ITH Pharma ApS founded?

ITH Pharma ApS was founded on 2 April 2024.

What is the equity of ITH Pharma ApS?

Equity was DKK 655k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.